Prudential Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.17M Sell
376,384
-4,800
-1% -$104K 0.01% 711
2025
Q1
$9.24M Sell
381,184
-172,240
-31% -$4.18M 0.01% 616
2024
Q4
$11.5M Buy
553,424
+128,525
+30% +$2.68M 0.02% 551
2024
Q3
$8.45M Buy
424,899
+229,840
+118% +$4.57M 0.01% 749
2024
Q2
$3.02M Sell
195,059
-32,630
-14% -$505K ﹤0.01% 1169
2024
Q1
$3.63M Buy
227,689
+9,359
+4% +$149K 0.01% 1112
2023
Q4
$3.67M Sell
218,330
-357,110
-62% -$6M 0.01% 1099
2023
Q3
$6.73M Sell
575,440
-131,764
-19% -$1.54M 0.01% 785
2023
Q2
$9.5M Sell
707,204
-37,405
-5% -$503K 0.01% 669
2023
Q1
$12.3M Sell
744,609
-72,281
-9% -$1.2M 0.02% 582
2022
Q4
$15.2M Sell
816,890
-675,735
-45% -$12.6M 0.03% 497
2022
Q3
$19.1M Buy
1,492,625
+209,580
+16% +$2.69M 0.03% 454
2022
Q2
$8.99M Sell
1,283,045
-144,400
-10% -$1.01M 0.01% 703
2022
Q1
$11.8M Buy
1,427,445
+174,245
+14% +$1.44M 0.02% 672
2021
Q4
$8.48M Sell
1,253,200
-402,552
-24% -$2.73M 0.01% 773
2021
Q3
$8.78M Sell
1,655,752
-273,734
-14% -$1.45M 0.01% 770
2021
Q2
$11.1M Sell
1,929,486
-819,693
-30% -$4.71M 0.02% 727
2021
Q1
$12.7M Buy
2,749,179
+77,842
+3% +$359K 0.02% 668
2020
Q4
$8.92M Buy
2,671,337
+223,500
+9% +$746K 0.02% 788
2020
Q3
$7.27M Buy
2,447,837
+1,026,088
+72% +$3.05M 0.01% 795
2020
Q2
$6.57M Buy
1,421,749
+392,281
+38% +$1.81M 0.01% 857
2020
Q1
$3.96M Sell
1,029,468
-741,815
-42% -$2.86M 0.01% 1012
2019
Q4
$6.64M Buy
1,771,283
+716,807
+68% +$2.69M 0.01% 1007
2019
Q3
$5.6M Buy
1,054,476
+621,547
+144% +$3.3M 0.01% 1062
2019
Q2
$1.66M Buy
432,929
+334,185
+338% +$1.28M ﹤0.01% 1680
2019
Q1
$503K Sell
98,744
-41,134
-29% -$210K ﹤0.01% 2083
2018
Q4
$268K Sell
139,878
-80,525
-37% -$154K ﹤0.01% 2159
2018
Q3
$833K Sell
220,403
-87,467
-28% -$331K ﹤0.01% 1920
2018
Q2
$960K Buy
307,870
+134,200
+77% +$418K ﹤0.01% 1914
2018
Q1
$415K Buy
173,670
+53,500
+45% +$128K ﹤0.01% 2060
2017
Q4
$469K Buy
+120,170
New +$469K ﹤0.01% 2034